Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials. Mascarenas-Garcia M, Rivero-de-Aguilar A, Perez-Rios M, Ruano-Ravina A, et al. J Neurol Neurosurg Psychiatry 2023 Aug 4:jnnp-2023-331733.

Read + Share

Amedeo Smart

Independent Medical Education

Mascarenas-Garcia M, Rivero-de-Aguilar A, Perez-Rios M, Ruano-Ravina A, et al. Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials. J Neurol Neurosurg Psychiatry 2023 Aug 4:jnnp-2023-331733.
PMID: 37541785